Showing results (221-230 of 495) with videos related to

Sort By:
Pageof 50
Medical Care|February 9, 2021
Associations Between Copays, Coverage Limits for Opioid Use Disorder Medications, and Prescribing in Medicaid, 2018Rachel E Barenie, Aaron S Kesselheim, Theodore Tsacogianis, et al.
JAMA Internal Medicine|February 22, 2021
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated ApprovalAvi Cherla, Huseyin Naci, Aaron S Kesselheim, et al.
BMJ Quality & Safety|April 27, 2013
Speaking the same language? International variations in the safety information accompanying top-selling prescription drugsAaron S Kesselheim, Jessica M Franklin, Jerry Avorn, et al.
Health Affairs (Project Hope)|July 8, 2020
Lessons From The Impact Of Price Regulation On The Pricing Of Anticancer Drugs In GermanyVictoria D Lauenroth, Aaron S Kesselheim, Ameet Sarpatwari, et al.
Annals of Internal Medicine|July 17, 2023
Moving Naloxone Over the Counter Is Necessary but Not SufficientJohn C Messinger, Leo Beletsky, Aaron S Kesselheim, et al.
BMJ (Clinical Research Ed.)|September 25, 2015
Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort studyAaron S Kesselheim, Bo Wang, Jessica M Franklin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Trends in Pricing and Generic Competition Within the Oral Antibiotic Drug Market in the United StatesJonathan D Alpern, Lei Zhang, William M Stauffer, et al.
JAMA|August 25, 2018
Medicare Spending on Brand-name Combination Medications vs Their Generic ConstituentsChana A Sacks, ChangWon C Lee, Aaron S Kesselheim, et al.
Drug Discovery Today|November 20, 2025
Discovering a transformative cancer drug: the case of ibrutinibLiam Bendicksen, Lawrence King, Edward R Scheffer Cliff, et al.
Drug Discovery Today|October 25, 2025
Therapeutic value and regulatory characteristics of breakthrough therapy drugs in the USA and China (2021-2023): a retrospective cohort studyXiangyun Mao, Haoyu Yin, Xiaoyin Bai, et al.
Pageof 50